The biggest advice I would give to practices and care teams trying to really engage patients more is be innovative, explained James Hamrick, MD, senior medical director at Flatiron Health.
The biggest advice I would give to practices and care teams trying to really engage patients more is be innovative, explained James Hamrick, MD, senior medical director at Flatiron Health.
Transcript
What advice would you give a provider looking to implement patient engagement programs into practice?
The biggest advice I would give to practices and care teams trying to really engage patients more is be innovative. Don’t be afraid; if you have good ideas or you see feedback from patients that you think could make sense in your practice, then be willing to innovate. Now, you have to gather support form stakeholders. There’s invariably going to be people that may say, “Here’s why this idea won’t work,” or “We would love to do that but we don’t have the resources,” but continue to push and then track your results. It’s really important when you invest in some sort of new type of patient engagement program at your practice that you understand what does success look like and how are you going to track that?
As soon as I say that, I will say the other key thing is the old saying, “Don’t let perfect be the enemy of good.” Don’t expect to transform everything and have wonderful, beautiful measures right after you start a project. The first things are probably going to be very simple measures like “Does the team actually participate and buy in?” or “How many patients actually were touched by this new workflow?” So, don’t be discouraged if it’s hard to show the return on investment early, because often the best programs take a while to get started and get buy in and make that culture change that’s going to make it work.
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
FDA Approves Tislelizumab for Advanced or Metastatic ESCC After Chemotherapy
March 15th 2024The FDA has approved tislelizumab-jsgr (Tevimbra) for single-agent use in adult patients with unresectable or metastatic esophageal squamous cell carcinoma following prior systemic chemotherapy that did not include a PD-1/PD-L1 inhibitor.
Read More
Navigating the Mental Health Challenges of Cancer Diagnosis, Treatment, and Survivorship
March 12th 2024Stress has potential links to worse outcomes in cancer, such as decreased quality of life and greater risks of disease progression and metastasis. There is a complex mix of emotions patients with cancer experience.
Read More